Also, another study showed that PTL and DMAPT could block the NF-κB pathway in chronic myeloid leukemia (CML) cells by inhibition of p65 phosphorylation (24). The gene discussed is NFKB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.